Antonio Cicione

Disclosure information not submitted.

Presentation(s):

• MP48-06: Adverse events related to Darolutamide treatment: analysis of “real life” data from EudraVigilance (EV) and the Food and Drug Administration (FDA) database entries

  Sunday, May 15, 2022
  2:45 PM – 4:00 PM